文献速递胃肠外科围术期管理与 ERAS

胃旁路术与袖状胃切除术后的主要不良心脏事件比较

Major Adverse Cardiac Events After Gastric Bypass vs Sleeve Gastrectomy.
PubMed 文献 · JAMA Surg · 2025-01-01

这项基于瑞士行政索赔数据的逆概率加权队列研究纳入2012至2022年间接受代谢减重手术的成人,比较胃旁路术与袖状胃切除术与主要不良心脏事件(MACE)的关联。中位随访5.1年,胃旁路术组MACE发生率为1.9%,袖状胃切除术组为3.0%(HR 0.75,95%CI 0.64-0.88),差异主要由急性心肌梗死率较低驱动。

要点

  • 胃旁路术与较低的MACE风险相关(HR 0.75,95%CI 0.64-0.88)。
  • 差异主要来自急性心肌梗死率降低(HR 0.63,95%CI 0.46-0.86)。
  • 缺血性卒中、心衰住院和全因死亡无显著差异。

核心结论

  • 在代谢减重手术患者中,胃旁路术与袖状胃切除术相比,随访期内MACE发生率更低。

研究设计与样本

  • 基于瑞士行政索赔数据的全国性、逆概率加权队列研究,纳入2012年1月至2022年12月接受胃旁路术或袖状胃切除术的成人。

主要发现

  • 加权后中位随访5.1年(IQR 2.6-7.6),胃旁路术组MACE发生577例(1.9%),袖状胃切除术组264例(3.0%)。
  • 两组MACE发生率分别为3.96和5.10每1000人年(HR 0.75;95%CI 0.64-0.88)。
  • 急性心肌梗死发生率胃旁路术组更低(HR 0.63;95%CI 0.46-0.86)。
  • 缺血性卒中、心衰住院和全因死亡在两组间无差异。
  • 除翻修手术和术后即刻并发症较高外,短期和长期次要结局均偏向胃旁路术。

临床怎么用

  • 在权衡减重手术方式时,胃旁路术可能为患者带来额外的心脏保护获益。
  • 需结合患者个体情况讨论胃旁路术与袖状胃切除术在MACE风险上的差异。
  • 胃旁路术翻修手术和术后即刻并发症风险较高,决策时需综合考量。

局限性

  • 研究基于行政索赔数据,可能存在编码偏倚和未测量混杂。
  • 原文未报告其他局限性信息。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Metabolic bariatric surgery is the most effective and durable treatment for weight loss and improvement of cardiovascular diseases. With sleeve gastrectomy now surpassing gastric bypass as the most common procedure worldwide, comparing these procedures' associations with major adverse cardiac events (MACE) is needed. OBJECTIVE: To compare the risk of MACE among individuals undergoing gastric bypass or sleeve gastrectomy. DESIGN, SETTING, AND PARTICIPANTS: This population-based, inverse probability-weighted cohort study was conducted using administrative claims data from Switzerland among adults undergoing gastric bypass or sleeve gastrectomy for obesity treatment between January 2012 and December 2022. Inpatient individuals with a primary or secondary discharge procedure code for gastric bypass or sleeve gastrectomy were eligible for inclusion. Data were analyzed from April 2024 to September 2025. EXPOSURE: Gastric bypass vs sleeve gastrectomy. MAIN OUTCOMES AND MEASURES: A weighted cohort was analyzed to study the primary outcome of 4-point MACE, including acute myocardial infarction, ischemic stroke, hospitalizations for heart failure, and all-cause mortality. Secondary outcomes were the individual components of MACE, surgical reinterventions, and associated complications. RESULTS: Of 39 067 patients, 30 270 patients (77.5%) underwent gastric bypass and 8798 patients (22.5%) underwent sleeve gastrectomy. Median (IQR) patient age was 42 (35-50) years, and 28 560 patients (73.1%) were women. A total of 23 708 patients (60.7%) had a body mass index (calculated as weight in kilograms divided by height in meters squared) of 40 or higher. After weighting, over a median (IQR) follow-up of 5.1 years (2.6-7.6), the primary outcome occurred in 577 patients in the gastric bypass group (1.9%) and 264 patients in the sleeve gastrectomy group (3.0%), with incidence rates of 3.96 and 5.10 per 1000 patient-years, respectively (hazard ratio [HR], 0.75; 95% CI, 0.64-0.88). This difference was primarily driven by lower rates of acute myocardial infarction (HR, 0.63; 95% CI, 0.46-0.86). No differences were observed in ischemic stroke, hospitalization for heart failure, and all-cause mortality. Both short- and long-term secondary outcomes favored gastric bypass over sleeve gastrectomy, except for higher rates of revision surgery and immediate postoperative complications. CONCLUSIONS AND RELEVANCE: In this inverse probability-weighted cohort study, for patients undergoing metabolic bariatric surgery, gastric bypass was associated with lower rates of MACE than sleeve gastrectomy over a follow-up period of up to 11 years. Known postoperative complications were confirmed for both gastric bypass and sleeve gastrectomy.

来源:JAMA Surg,查看原文。版权归原作者所有。

引用

  1. Wildisen S, Laager R, Struja T, et al. Major Adverse Cardiac Events After Gastric Bypass vs Sleeve Gastrectomy. JAMA Surg. 2025. PMID: 40332926. doi:10.1001/jamasurg.2025.1065

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。